Strong demand for mRNA-based vaccines and therapies continues to fuel market growth in diverse therapeutic areas, including oncology, infectious diseases, and rare genetic disorders.

“According to SNS Insider, the mRNA Therapeutics Market was valued at USD 11.82 billion in 2023 and is projected to grow to USD 48.65 billion by 2032, registering a robust CAGR of 17.04% during the forecast period of 2024-2032.”